SunWay Biotech Co., LTD. (TPEX:1271)
Taiwan · Delayed Price · Currency is TWD 62.10
-1.90 (-2.97%)
Jun 18, 2026, 2:46 PM CST
SunWay Biotech Co., LTD. Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 101.5 | 118.57 | 46.09 | 30.04 | 168.76 |
Depreciation & Amortization | 69.37 | 82.46 | 23.67 | 6.4 | 19.62 |
Other Amortization | 1.39 | 1.13 | 1.24 | 1.36 | 0.11 |
Loss (Gain) From Sale of Assets | -0.2 | - | - | - | - |
Asset Writedown & Restructuring Costs | - | - | - | - | 0.14 |
Loss (Gain) on Equity Investments | -20.32 | 0.04 | - | - | - |
Stock-Based Compensation | 2.73 | - | - | - | 0.29 |
Provision & Write-off of Bad Debts | - | - | 0.62 | -0.36 | 0.45 |
Other Operating Activities | -15.04 | 1.93 | -1.62 | 6.74 | 1.45 |
Change in Accounts Receivable | 4.2 | -65.59 | 5.23 | -43.72 | -56.92 |
Change in Inventory | 19.88 | -39.81 | 9.91 | -5.97 | 13.11 |
Change in Accounts Payable | -19.27 | 26.16 | -36.25 | 33.64 | -0.63 |
Change in Unearned Revenue | 31.3 | -2.24 | 0.28 | 6.75 | -3.11 |
Change in Other Net Operating Assets | 47.36 | 34.27 | 6.81 | 7.71 | 17.5 |
Operating Cash Flow | 222.89 | 156.92 | 55.98 | 42.58 | 160.76 |
Operating Cash Flow Growth | 42.04% | 180.30% | 31.47% | -73.51% | -11.60% |
Capital Expenditures | -101.64 | -116.19 | -46.24 | - | -9.71 |
Sale of Property, Plant & Equipment | 0.2 | - | - | - | - |
Cash Acquisitions | - | - | 293.22 | - | - |
Sale (Purchase) of Intangibles | -2.38 | -7.49 | - | -1.52 | -0.09 |
Investment in Securities | -650 | -1.39 | - | - | - |
Other Investing Activities | -0.77 | -0.73 | -28.21 | -1.96 | -1.06 |
Investing Cash Flow | -754.59 | -125.8 | 218.78 | -3.48 | -10.86 |
Short-Term Debt Issued | 200 | - | - | - | 50 |
Long-Term Debt Issued | 457.58 | - | - | - | - |
Total Debt Issued | 657.58 | - | - | - | 50 |
Short-Term Debt Repaid | - | -7.51 | -58.06 | -52.51 | -50 |
Long-Term Debt Repaid | -17.14 | -32.64 | -11.25 | -1.38 | -9.88 |
Total Debt Repaid | -17.14 | -40.15 | -69.31 | -53.9 | -59.88 |
Net Debt Issued (Repaid) | 640.44 | -40.15 | -69.31 | -53.9 | -9.88 |
Issuance of Common Stock | - | - | 76.5 | 70 | 4.2 |
Repurchase of Common Stock | -20.99 | - | - | -15 | - |
Common Dividends Paid | -80.32 | -59.39 | -42.65 | -6.44 | -92.73 |
Other Financing Activities | - | -0.26 | - | - | - |
Financing Cash Flow | 539.13 | -99.8 | -35.46 | -5.33 | -98.4 |
Foreign Exchange Rate Adjustments | -0.11 | 0.19 | -0.68 | - | -0.4 |
Net Cash Flow | 7.32 | -68.49 | 238.62 | 33.77 | 51.1 |
Free Cash Flow | 121.25 | 40.73 | 9.75 | 42.58 | 151.05 |
Free Cash Flow Growth | 197.70% | 317.89% | -77.11% | -71.81% | -16.22% |
Free Cash Flow Margin | 12.21% | 4.20% | 1.71% | 10.01% | 39.70% |
Free Cash Flow Per Share | 2.01 | 0.67 | 0.32 | 2.11 | 4.40 |
Cash Interest Paid | 11.26 | 5.54 | 2.09 | 1.32 | 0.09 |
Cash Income Tax Paid | 28.96 | 21.52 | 11.76 | 2.88 | - |
Levered Free Cash Flow | 90.2 | 5.4 | -78.44 | -43.77 | 85.6 |
Unlevered Free Cash Flow | 97.24 | 8.87 | -77.13 | -43.05 | 85.66 |
Change in Working Capital | 83.47 | -47.21 | -14.02 | -1.59 | -30.05 |